Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. - Wikidata - wikimedia - TriplyDB

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

http://www.wikidata.org/entity/Q33186142

about

Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature Predictive and prognostic markers in neuro-oncology.Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas 1p/19q testing has no significance in the workup of glioblastomas.Absence of common somatic alterations in genes on 1p and 19q in oligodendrogliomas Extracranial skeletal metastasis in anaplastic oligodendroglioma: case report and review of the literature.Biology, genetics and imaging of glial cell tumours Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis.Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EOR EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q.The future of high-grade glioma: Where we are and where are we going.Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments.'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas.Automated Analysis of 1p/19q Status by FISH in Oligodendroglial Tumors: Rationale and Proposal of an Algorithm.Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization.Molecular genetic analysis of oligodendroglial tumors.Molecular markers of gliomas: a clinical approach.Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome.A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors.Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas.Anaplastic oligodendroglioma.Molecular diagnostics of gliomas: state of the art.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Molecular profiling of gliomas: potential therapeutic implications.Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics Correlation of in vitro infiltration with glioma histological type in organotypic brain slices.Complete Radiologic Response in an Anaplastic Oligodendroglioma Treated with Temozolomide and Bevacizumab.Something old and something new about molecular diagnostics in gliomas.

P2860

Q24194645-37A47990-3501-4E9B-9181-109813B038BA Q24242968-BCA6154C-0396-4FCE-9816-2606064AFACB Q24685905-E07C3DB2-BF50-4243-B29C-A295C788F40E Q26863688-E6610F60-7E78-4BAD-89C3-0D38E506EBD6 Q33311133-C70B86C8-F365-481C-A424-C2C83B1B418D Q33410196-93BCE4E7-9228-4865-827A-9036D222F9FB Q33636469-9BB67C7C-E5C6-4AFF-8D17-3C271BDD41DD Q33638116-E1460E03-D0AF-4299-BF01-DBBC6FE894E3 Q33784207-43E01E35-3092-4FC0-91BF-8FC8A33BE4A4 Q33893445-7D32B3C3-60D2-4943-8171-145113194A97 Q33961691-31357C6E-FE07-4C70-A46D-1406E09D5091 Q33984130-17D026F5-4B80-4C80-9F66-CFB0E7DB0222 Q34203979-6DD4F251-D655-48E8-AB90-353B193DF403 Q34213759-9A843A27-89B2-4872-922C-0068AD30CEFB Q34359802-D34A7AC6-52AF-4C59-B7A3-296E4F23D84E Q34500050-7ACE7502-C4FA-461C-8CC8-DE0403C7631F Q34523475-BFAD91A6-DE6F-4F86-A901-B3A312FDC700 Q34594410-E2964805-6C84-4301-9876-B1B91D820A9F Q35114090-693DF990-119A-4413-AB72-E95149D13BAD Q35161909-194F9B4D-417F-4FEC-9503-DC2E29B3B2AB Q35575628-E98F87F2-B354-46DC-B44C-E6582CA34AF8 Q35634042-6661B0FF-7B4C-46E1-90B3-9801D3EFBB86 Q35681251-B0859816-E574-4F26-A54B-4DF6310CAB9D Q35790152-7E4B2629-4021-4435-B75C-FB759DAB0355 Q36044175-92CC2195-DF2D-4DBD-BD93-6F371B0EEA62 Q36523374-EC3D68EA-48CE-4D0B-80C2-F947EBEF8042 Q36612016-D01AD97D-73AF-4F76-B7B6-2B0B47CF82C3 Q36840568-3D0403FE-0D16-4EF8-89C3-EE325B1B707C Q36919406-E503D790-D48C-4289-A3D8-32AFB62AE2CE Q37580501-997467F4-E419-4A24-86A4-C6987C5392F7 Q37714906-924C1F96-4C68-4928-9831-121D589671D2 Q37780495-D13FD2D5-9E95-4DA8-B7B8-B039EB3031CD Q38108186-0FDF0224-640B-45B1-8ECF-65FAC5BF2645 Q38539422-83D7ECA2-222D-4344-BDED-03CFE34FAB0B Q38626948-049FCEA8-8E62-4F5F-B064-D9B0E0FD7278 Q38843310-B855C41F-9142-4350-8809-E8551734A19F Q41885614-E65CD580-F342-4CDE-BF89-28C44F2CE369 Q42157104-C93707E0-A37C-483E-9F37-9BF276BB99FD Q42553392-EAC5CEB5-B9D9-4718-9996-18637DB673BD Q43238974-6C52BAC3-C86C-4694-ACD1-6EB4BD2439A0

P2860

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

http://www.wikidata.org/entity/Q33186142

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

@ast

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

@en

type

label

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

@ast

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

@en

prefLabel

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

@ast

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

@en

P1433

Q33186142-C486C666-F939-497C-BE60-6EA038279C4F

P1476

Q33186142-85B178A7-CE18-4AA4-9E3F-51E712DB3518

P2093

Q33186142-12A84272-8581-42AC-88E6-74FBD9239281

Q33186142-311F1136-787C-4AE3-A438-F733A29D1BDB

Q33186142-50B2CBBD-B6E1-46F0-A84D-53104DCC8CD5

Q33186142-5C1AE55C-709D-4EC6-A1CD-A77F2A78FE08

Q33186142-7D5DEA1D-4B52-4BFB-9BE5-96BD04642C67

Q33186142-D7E5CC68-CE44-4B9D-B024-193F42A2A445

Q33186142-EA239D58-9798-41F4-918B-26967C310B78

P304

Q33186142-F856B1CC-ABF6-4670-A90C-448976758F4A

P31

Q33186142-49051216-214D-4187-B939-0C3273861BBF

P356

Q33186142-359B48FB-A67C-428C-B535-6E9D6CF128BD

P407

Q33186142-972B05F7-D137-4FF6-8DD5-3703CF9439AC

P433

Q33186142-7F594E34-343A-4CCB-B6A1-AF559EF53EFB

P478

Q33186142-12AE2562-9EED-48A8-ABC0-BB9B47553240

P50

Q33186142-2D3180AA-C818-419B-AF0E-EFFFFCDFBAE0

Q33186142-2DD53419-4F1F-45E9-A643-A2C41E40BF7C

P577

Q33186142-F53D230E-9C31-475B-AEF5-ADC7717113E4

P5875

Q33186142-7EFFD866-B50C-4419-AB0D-4820347DE9C0

P698

Q33186142-3F10BD8D-CE1E-4A21-91DA-6A5B03DBC135

P921

Q33186142-BCA1555E-6A7E-4502-9D6C-962FBEEADC98

P356

P1433

P1476

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features

@en

P2093

Johan M Kros

http://www.w3.org/2001/XMLSchema#string

K Langenberg

http://www.w3.org/2001/XMLSchema#string

Ludo Uytdewilligen

http://www.w3.org/2001/XMLSchema#string

Peter A Sillevis Smitt

http://www.w3.org/2001/XMLSchema#string

Robert B Jenkins

http://www.w3.org/2001/XMLSchema#string

Wilfried Graveland

http://www.w3.org/2001/XMLSchema#string

Winand Dinjens

http://www.w3.org/2001/XMLSchema#string

P304

1276-1284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.11187

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Leendert Looijenga

Martin J van den Bent

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10889681

http://www.w3.org/2001/XMLSchema#string

P698

12599236

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte